Non-invasive imaging to the blastocyst stage for the detection of human embryonic aneuploidy

1. A method for selecting a human embryo for transfer or cryopreservation based on an evaluation of quality of embryo growth in vitro, comprising:

measuring an imaging parameter (P3) of the time between 3rd and 4th cell or second and third mitosis of the test embryo and measuring at least one imaging parameter selected from: (P4) time between 4th and 5th cell; (P5) time between 5th cell and compaction and (P6) time between 5th cell and cavitation;

comparing the P3 imaging parameter and the at least one imaging parameter from the test embryo to a reference imaging parameter; determining whether the imaging parameters from the test embryo differs from the reference imaging parameters, wherein the P3 reference imaging parameter is less than about 1 hour, the reference P4 is about 15 hours, the reference P5 is less than about 28.6 hours, the reference P6 is less than about 66.4 hours; wherein a difference indicates a lack of embryo quality;

providing an evaluation of the test embryo quality based on comparison and determination; and

selecting an embryo for transfer or cryopreservation based on the evaluation of quality.

2. The method of claim 1 wherein embryo quality comprises one or both of morphology and ploidy.

3. The method of claim 2 , wherein high quality embryos have one or more of: shortened P5 relative to the reference imaging parameter; shortened P6 relative to the reference imaging parameter, and lengthened P4 relative to a reference imaging parameter.

4. The method of claim 1 , wherein the method further comprises measuring an imaging parameter (P3) of the time between 3rd and 4th cell (or second and third mitosis) of the test embryo and wherein imaging parameters P3, P4, P5 and P6 from the test embryo are compared to reference imaging parameters.

5. The method of claim 1 , wherein a classification tree is constructed wherein if P5 is <28.6 h and P6 occurs <66.4 h; or if P6 occurs <66.4 h and P3 is <0.96 h, the blastocyst is predicted to be euploid with a specificity of 94%, sensitivity of 71%, PPV of 96%, and NPV 60%.

6. The method of claim 1 , where the embryos are human pre-implantation embryos derived from oocytes that have been matured in vitro.

7. The method of claim 1 , where the measurements are used to rank a group of embryos based on blastocyst morphology.

8. The method of claim 1 , comprising using time-lapse imaging to measure the at least one parameter.

9. The method of claim 1 , wherein evaluation of test embryo quality is performed as a series of steps embodied as a program of instructions executable by computer and performed by means of software components loaded into the computer.

10. The method of claim 2 , wherein embryo quality comprises ploidy.